Wall Street Zen upgraded shares of Neogen (NASDAQ:NEOG – Free Report) from a buy rating to a strong-buy rating in a report published on Saturday,Wall Street Zen reports.
Several other equities research analysts also recently issued reports on the stock. Guggenheim restated a “buy” rating and issued a $14.00 price objective (up from $12.00) on shares of Neogen in a research note on Wednesday, September 30th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Neogen in a research note on Wednesday, November 4th. Finally, Piper Sandler upgraded shares of Neogen from a “neutral” rating to an “overweight” rating and upped their target price for the company from $13.00 to $14.00 in a research note on Wednesday, August 26th. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $12.67.
View Our Latest Stock Report on Neogen
Neogen Stock Performance
Shares of NASDAQ NEOG traded up $0.04 during trading hours on Friday, hitting $11.23. 1,802,182 shares of the company’s stock were exchanged, compared to its average volume of 3,010,526. The company’s 50-day moving average price is $12.24 and its 200-day moving average price is $10.52. Neogen has a 1-year low of $5.37 and a 1-year high of $14.26. The stock has a market capitalization of $2.45 billion, a price-to-earnings ratio of -44.92, a PEG ratio of 4.00 and a beta of 1.86. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.90 and a quick ratio of 2.92.
Neogen (NASDAQ:NEOG – Get Free Report) last released its earnings results on Tuesday, October 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Neogen had a positive return on equity of 3.29% and a negative net margin of 6.35%. The firm had revenue of $222.80 million for the quarter, compared to analyst estimates of $208.18 million. During the same quarter last year, the firm posted $0.04 EPS. The company’s revenue was up 6.5% on a year-over-year basis. On average, sell-side analysts expect that Neogen will post 0.28 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Marshall Wace LLP boosted its holdings in Neogen by 128.8% during the third quarter. Marshall Wace LLP now owns 137,411 shares of the company’s stock valued at $1,759,000 after purchasing an additional 77,349 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Neogen by 1.4% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,537,645 shares of the company’s stock valued at $45,282,000 after purchasing an additional 49,399 shares during the period. Bleakley Financial Group LLC bought a new stake in shares of Neogen in the 3rd quarter valued at approximately $223,000. Heartland Advisors Inc. raised its holdings in shares of Neogen by 10.0% in the 3rd quarter. Heartland Advisors Inc. now owns 1,100,000 shares of the company’s stock worth $14,080,000 after buying an additional 100,000 shares in the last quarter. Finally, Private Advisor Group LLC acquired a new position in shares of Neogen in the 3rd quarter worth approximately $1,575,000. Institutional investors and hedge funds own 96.73% of the company’s stock.
Neogen Company Profile
Neogen Corporation develops and markets products and services focused on food and animal safety. Its offerings help food producers, processors, laboratories and livestock producers detect risks, support animal health and meet safety and quality requirements. Neogen’s food safety products include tests for foodborne pathogens, allergens, toxins and sanitation indicators, as well as related laboratory supplies and services. Its animal safety offerings include veterinary instruments, animal health products, biosecurity solutions and genetic testing services for livestock.
Featured Articles
- Five stocks we like better than Neogen
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
